NCT05559528View on ClinicalTrials.gov

BRaziLian outcomE for metAStatic breasT Cancer

UnknownOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

September 13, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Metastatic Breast CancerBreast Cancer Stage IV
Trial Locations (1)

04004-030

RECRUITING

Hcor, São Paulo

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Hospital do Coracao

OTHER

NCT05559528 - BRaziLian outcomE for metAStatic breasT Cancer | Biotech Hunter | Biotech Hunter